XML 79 R41.htm IDEA: XBRL DOCUMENT v3.3.0.814
LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT WITH ASET THERAPEUTICS, LLC (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Nov. 25, 2014
Feb. 28, 2015
Investment amount received   $ 250,000
Reimbursement revenue   75,000
Investment required by company   1,000,000
Costs and Expenses [Member]    
Reimbursement revenue $ 150,000 150,000
Research and Development Expense [Member]    
Reimbursement revenue 75,000 75,000
Minimum [Member]    
Other Commitment Due   5,000
Investment amount received   $ 1,250,000
Equity ownership   20.00%
Maximum [Member]    
Other Commitment Due   $ 25,000
Maximum [Member] | Costs and Expenses [Member]    
Reimbursement revenue $ 50,000 $ 50,000